Overview Study of DSP-7888 in Patients With Myelodysplastic Syndrome Status: Completed Trial end date: 2020-03-01 Target enrollment: Participant gender: Summary This is a phase 1/2, uncontrolled, open-label, multicenter study in patients with MDS for whom no effective therapies currently exist. Phase: Phase 1/Phase 2 Details Lead Sponsor: Sumitomo Dainippon Pharma Co., Ltd.